Aspirin for Stroke Prevention in Elderly Patients With Vascular Risk Factors: Japanese Primary Prevention Project [Clinical Sciences]
Conclusions—
Aspirin did not show any net benefit for the primary prevention of stroke in elderly Japanese patients with risk factors for stroke, whereas age >70 years, smoking, and diabetes mellitus were risk factors for stroke regardless of aspirin treatment.
Clinical Trial Registration—
URL: http://www.clinicaltrials.gov. Unique identifier: NCT00225849.
Source: Stroke - Category: Neurology Authors: Uchiyama, S., Ishizuka, N., Shimada, K., Teramoto, T., Yamazaki, T., Oikawa, S., Sugawara, M., Ando, K., Murata, M., Yokoyama, K., Minematsu, K., Matsumoto, M., Ikeda, Y., on behalf of the JPPP Study Group Tags: Cardiovascular Disease, Primary Prevention, Race and Ethnicity, Risk Factors Clinical Sciences Source Type: research
More News: Aspirin | Cardiology | Cardiovascular | Clinical Trials | Diabetes | Diabetes Mellitus | Endocrinology | Heart | Hemorrhagic Stroke | Hypertension | Ischemic Stroke | Neurology | Smokers | Stroke | Study